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Abstract
Background: Desmoid tumor is a rare entity, and most desmoid tumors are located in abdominal
wall or extra-abdominal tissues. Occurrence of desmoid tumor in mesentry is extremely rare.
Case presentation: we report a mesenteric desmoid tumor in a 73-years-old woman who had
undergone total gastrectomy reconstructed with jejunal pouch interposition for gastric carcinoma.
After 1 year, a tumor was originating from mesentery of the interposed jejunal pouch was
identified, and the patient underwent resection of the large mass which was found to invade
pancreas. Histological examination revealed desmoid tumor.
Conclusion: Desmoid tumor is rare, and it was difficult for the differential diagnosis of desmoid
tumor or recurrent tumor.
Background
Desmoid is derived from the Greek word "desmos",
meaning band-like. The tumors are defined as benign
fibrous tissue tumors arising in the musculoaponeurotic
structures throughout the body. There is no report of
metastasis for desmoid tumor, however, desmoid tumor
sometimes shows locally invasive growth [1]. Histological
examination usually shows uniformed mature fibroblasts
in both size and shape without karyomitosis [2]. An
annual incidence of desmoid is rare, and it is reported
only in 2–4 cases per 1 million populations [3]. Moreover,
desmoid tumors commonly occur as an extracolonic
manifestation of familial adenomatous polyposis (FAP),
especially Gardner syndrome [4]. There is no report of
intra-abdominal desmoid tumor after total gastrectomy,
originating from the interposed jejunal pouch.
Case presentation
A 73-years-old woman had undergone total gastrectomy
and D2 lymphadenectomy for gastric carcinoma, which
was pathologically diagnosed as stage I (T1, N1, H0, P0,
M0, CY0) by Japanese Classification of Gastric Carcinoma
2nd English edition[5]. The patient was followed-up by
computed tomography (CT), and there was no tumor at 1
year after the total gastrectomy. However, another year
later, she was admitted to Wakayama Medical University
hospital because of asymptomatic intra-abdominal
tumor. Laboratory investigations revealed a hemoglobin
(Hb) of 11.7 g/dl, while the levels of serum carcinoembry-
onic antigen (CEA), carbohydrate antigen 125 (CA125)
and carbohydrate antigen 19-9 (CA19-9) were within nor-
mal range. CT showed a 50 × 65 mm round-shaped solid
mass at the right side of the reconstructed jejunal pouch,
which showed weak enhancement at arterial phase by
contrast medium and local invasion into pancreas body
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(Figure. 1). Magnetic resonance imaging (MRI) showed a
low signal intensity of the mass in both T1-weighted and
T2-weighted images (Figure. 2). Abdominal ultrasound
revealed a hypoechoic mass without blood-flow.
At laparotomy, a 50 × 50 × 63 mm tumor was found to be
located in the mesentery of the jejunal pouch which was
used for reconstruction after total gastrectomy the mass
was adhered to the pancreas and it was possible to sepa-
rate it from pancreas. The tumor was excised and the
reconstruction was performed by double tract method
with esphagojejunostomy and jejunoduodenostomy. The
resected specimen was shown in Figure. 3. Microscopi-
cally, the tumor was composed of spindle-shaped fibrob-
lasts and copious collagen fibers by hematoxylin and
eosin stain. Collagen fibers were positive for immunolog-
ical staining of α-smooth muscle actin, confirming a
desmoid tumor (Figure. 4).
She is presently doing well and has no sign of any recur-
rent tumor 4 years after the operation.
Discussion
Surgical trauma, which is one of the most important etio-
logic factors for desmoid, can induce desmoid growth [6].
However, desmoid tumor originating from the jejunal
pouch, which had been interposed for reconstruction
after total gastrectomy for improvement of early postoper-
ative eating capacity, body weight and quality of life has
not been reported before. The desmoid tumor originated
from mesentery of reconstructed jejunal pouch, which has
not been affected surgical manipulation. Although anas-
tomotic leakage, abscess, wound infection, and fistula are
the known complications of total gastrectomy, occurrence
of desmoid tumor is rare [7]. In our case, there were no
postoperative complications, and there was no intra-
abdominal inflammatory lesion that could have led to
formation of desmoid tumor.
Mesenteric desmoid tumor is rare and has few symptoms
associated with this tumor, thus it is difficult to diagnose
Computed tomography (CT) shows round-shaped solid mass  at the right side of the reconstructed jejunal pouch, and  invaded into pancreas (arrow) Figure 1
Computed tomography (CT) shows round-shaped solid mass 
at the right side of the reconstructed jejunal pouch, and 
invaded into pancreas (arrow).
Magnetic resonance imaging (MRI) showed a low signal intensity of the mass in both T1-weighted (left) and T2-weighted images  (right) Figure 2
Magnetic resonance imaging (MRI) showed a low signal intensity of the mass in both T1-weighted (left) and T2-weighted images 
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these lesions early. In this case identification of a solid
mass at the intra-abdominal site after total gastrectomy,
possibility of a tumor recurrence was first considered and
later was considered as a solitary recurrent lymph node
metastasis, the diagnosis of desmoid was never consid-
ered. Surgery is the treatment of choice for desmoid
tumors.
The incidence of recurrence is reported to be 40%, with
surgical excision alone the recurrence rate of 77% in
mesenteric desmoid tumors have been reported [8]. Surgi-
cal margin has been reported as an important factor for
the recurrence of desmoid, the 10-year recurrence rate for
the patients with negative surgical margins is reported to
be 27%, whereas it is 54% for patients with positive surgi-
cal margins [9]. Use of adjuvant radiotherapy has
improved relapse rate for the patients with positive surgi-
cal margins and unresectable desmoid tumors [9]. It is
suggested that if surgical resection is not possible due to
some reason the patients should be treated by radiother-
apy.
A significant 3.5-fold increased risk for the development
of desmoid tumors among females has been reported,
particularly during or after pregnancy [4,10]. An increased
risk for the female gender is consistent with the observa-
tion that desmoid cells may express estrogen receptors
and are inhibited in their in vitro proliferation by anties-
trogen compounds [11]. Tamoxifen has antiestrogen
activity and it is possible to be effective in desmoid tumors
[2].
The dogma prevalent in medical oncology has been that
low-grade tumors with no known metastatic potential do
not kill patients and may not respond to chemotherapy
[12,13]. In this case, the patient was kept on observation
alone as i) the surgical margin was negative and ii)
advanced age of the patient. However, it was demon-
strated that desmoid tumors respond to chemotherapy.
Surgery was planned in this case as gastric cancer was early
stage, and the recurrence are rare. If the gastric cancer had
been advanced stage to begin with, we might have
planned chemotherapy with the diagnosis of recurrent
gastric cancer.
Conclusion
The desmoid tumor originating from the mesentry of the
jejunal pouch after total gastrectomy has not been
reported. It was a surprise, as desmoid tumor is rare and it
was difficult to think of desmoid tumor as differential
diagnosis.
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The tumor was composed of spindle-shaped fibroblasts and copious collagen fibers by hematoxylin and eosin stain (H&E) Figure 4
The tumor was composed of spindle-shaped fibroblasts and copious collagen fibers by hematoxylin and eosin stain (H&E). (A: × 
100 B: × 400).
The tumor was an elastic hard and white mass, and the size  was 50 × 50 × 63 mm Figure 3
The tumor was an elastic hard and white mass, and the size 
was 50 × 50 × 63 mm. It originated from the interposed 
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